These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29802039)

  • 1. Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis.
    Krause M; Zhu Y; Huhn M; Schneider-Thoma J; Bighelli I; Chaimani A; Leucht S
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):659-674. PubMed ID: 29802039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.
    Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
    J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):191-202. PubMed ID: 28219485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses.
    Zhu Y; Krause M; Huhn M; Rothe P; Schneider-Thoma J; Chaimani A; Li C; Davis JM; Leucht S
    Lancet Psychiatry; 2017 Sep; 4(9):694-705. PubMed ID: 28736102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.
    Harvey RC; James AC; Shields GE
    CNS Drugs; 2016 Jan; 30(1):27-39. PubMed ID: 26801655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
    Leucht S; Cipriani A; Spineli L; Mavridis D; Orey D; Richter F; Samara M; Barbui C; Engel RR; Geddes JR; Kissling W; Stapf MP; Lässig B; Salanti G; Davis JM
    Lancet; 2013 Sep; 382(9896):951-62. PubMed ID: 23810019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
    Arango C; Ng-Mak D; Finn E; Byrne A; Loebel A
    Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1195-1205. PubMed ID: 31758359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis.
    Rogdaki M; McCutcheon RA; D'Ambrosio E; Mancini V; Watson CJ; Fanshawe JB; Carr R; Telesia L; Martini MG; Philip A; Gilbert BJ; Salazar-de-Pablo G; Kyriakopoulos M; Siskind D; Correll CU; Cipriani A; Efthimiou O; Howes OD; Pillinger T
    Lancet Child Adolesc Health; 2024 Jul; 8(7):510-521. PubMed ID: 38897716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis.
    Krause M; Huhn M; Schneider-Thoma J; Bighelli I; Gutsmiedl K; Leucht S
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):32-45. PubMed ID: 30472164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders: A Systematic Review and Network Meta-Analysis.
    Yee CS; Bahji A; Lolich M; Vázquez GH; Baldessarini RJ
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):198-208. PubMed ID: 35020712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis.
    Krause M; Huhn M; Schneider-Thoma J; Rothe P; Smith RC; Leucht S
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1360-1370. PubMed ID: 30243680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
    Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
    Toren P; Ratner S; Laor N; Weizman A
    Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.
    Huhn M; Nikolakopoulou A; Schneider-Thoma J; Krause M; Samara M; Peter N; Arndt T; Bäckers L; Rothe P; Cipriani A; Davis J; Salanti G; Leucht S
    Lancet; 2019 Sep; 394(10202):939-951. PubMed ID: 31303314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis.
    Bai Z; Wang G; Cai S; Ding X; Liu W; Huang D; Shen W; Zhang J; Chen K; Yang Y; Zhang L; Zhao X; Ouyang Q; Zhao J; Lu H; Hao W
    Schizophr Res; 2017 Jul; 185():73-79. PubMed ID: 28108226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia.
    Dong S; Schneider-Thoma J; Bighelli I; Siafis S; Wang D; Burschinski A; Schestag K; Samara M; Leucht S
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; 274(4):917-928. PubMed ID: 37526675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.